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The protective effects of N-acetylcysteine (NAC) have been documented in experimental and clinical acute lung 
injury. However, the effect of NAC on the secretion of interleukin-8-(11-8) which is an important mediator of the 
pathogenesis of acute lung injury through the recruitment of neutrophils, has not been determined. In the present 
study, therefore, we examined the effect of NAC on IL-8 secretion by IL-la-stimulated bronchial epithelial cells. 
NAC inhibited IL-8 secretion by bronchial epithelial cells in a dose-dependent manner. In addition, the structurally 
unrelated antioxidants, butylated hydroxyanisole (BHA) and pyrrolidine dithiocarbamate (PDTC) also effectively 
inhibited secretion. These results indicated that an antioxidant-sensitive mechanism might be involved in inhibition 
of IL-8 secretion by IL-la-stimulated bronchial epithelial cells. The protective effects of NAC on acute lung injury 
have been suggested to be due to scavenging reactive oxygen intermediates (ROIs) and stimulation of glutathione 
synthesis. In addition to this, our results may provide an alternative explanation for the efficacy of NAC on acute 
lung injury. 
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Introduction 
Airway epithelial cells produce a variety of cytokines that 
initiate or/and amplify various airway inflammatory dis- 
eases (1). Of these cytokines, it has been suggested that IL-8 
is an important mediator of the pathogenesis of airway 
inflammatory diseases such as acute lung injury, pulmonary 
fibrosis and bronchial asthma through the recruitment of 
neutrophils (2). Therefore, the regulation of IL-8 secretion 
is thought to be an important strategy for treatment of 
airway inflammatory diseases. 
N-Acetylcysteine, a cysteine derivative, can react directly 
with ROIs and acts as a precursor to glutathione synthesis 
(3-5). NAC has been used for the treatment of acute 
respiratory distress syndrome and chronic bronchitis, and 
in animal models of acute lung injury, pulmonary fibrosis 
and acute pulmonary oxygen toxicity (6-12). The mechan- 
ism of the protective effects of NAC on these inflammatory 
diseases has been investigated. Several studies have sug- 
gested that its effects could be due to scavenging ROIs and 
stimulation of glutathione synthesis (3,4,12). However, the 
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effect of NAC on IL-8 which may contribute to the 
pathogenesis of airway inflammatory diseases (2) has not 
been determined. In the present study, therefore, we 
examined the effect of NAC on IL-8 secretion by airway 
epithelial cells in order to clarify the mechanism of the 
protective effects of NAC on airway inflammatory diseases. 
Materials and Methods 
REAGENTS 
Human recombinant IL-la and NAC were kindly provided 
by Ohtsuka Pharmaceutical Company Ltd (Tokushima, 
Japan) and Eisai Pharmaceutical Company Ltd (Tokyo, 
Japan), respectively. BHA and PDTC were obtained from 
Sigma Chemical Company Ltd (St Louis, MO). The pH of 
the medium containing NAC was adjusted to 7.4. 
CELL CULTURE 
Transformed human bronchial epithelial cell line (BEAS- 
2B) was provided by Dr Curis Harris (Laboratory of 
Human Carcinogenesis, National Cancer Institute, 
Bethesda, MD). The cells (1 x lo4 cells/well in 1 ml) were 
placed in a collagen-coated 24-well flat-bottomed tissue 
culture plate (Iwaki, Tokyo, Japan) using Ham’s F12 
medium containing 1% penicillin-streptomycin, 5 pg ml - ’ 
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of insulin (GIBCO, Grand Island, NY), 5pg ml ~ ’ of 
transferring (GIBCO), 25 ng ml - ’ of epidermal growth 
factor (Collaborative Research, Lexington, MA), 
15pgml-’ of endothelial cell growth supplement 
(Collaborative Research), 2 x 10 - lo M triiodothyronin 
(GIBCO), and 10 - ’ M hydrocortisone (GIBCO). Cells were 
grown until they were subconfluent and the medium was 
changed. In order to examine the effect of NAC, BHA or 
PDTC on IL-la-induced cytokine secretion by BEAS-2B, 
cells that had been pre-incubated with 1 ml of fresh medium 
containing NAC, BHA or PDTC for 1 h were stimulated 
with 10~1 of IL-la preparation and cultured for the desired 
times at 37°C in a 5% humidified atmosphere. At the end of 
culture periods, the culture supernatants were harvested, 
centrifuged and the supernatants were collected, filtered 
with a Millipore filter and stored at - 80°C until assay. 
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MEASUREMENT OF IL-S (b) 24 h 
The concentrations of IL-8 in the culture supernatants from 
BEAS-2B were measured by commercially available IL-8 
ELISA kits (Amersham International, Aylesbury, U.K.). 
ELISA was performed according to the manufacturer’s 
instructions. All samples were assayed in duplicate. IL-8 
standards prepared in preincubation medium containing 
NAC, BHA or PDTC refuted assay interference. 
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STATISTICAL ANALYSIS 
Statistical significance was analysed using analysis of vari- 
ance (ANOVA). P values less than 0.05 were considered 
significant. 
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Results 
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First, we examined a time- and dose-dependent induction of 
IL-8 secretion by BEAS-2B. To this end, the culture 
supernatants from BEAS-2B stimulated with various con- 
centrations of IL-la were harvested at 8 and 24 h after 
cultivation. The time-course of IL-8 secretion in the culture 
supernatants is shown in Fig 1. The concentrations of IL-8 
in the culture supernatants increased in a dose-dependent 
manner. At any dose of IL-la employed, the concentrations 
of IL-8 were higher in the culture supernatants harvested at 
24 h than in those at 8 h, indicating that IL-8 secretion was 
time-dependent. 
FIG. 1. Time- and dose-dependent IL-8 secretion by 
IL-la-stimulated bronchial epithelial cells. Bronchial 
epithelial cells (BEAS-2B) were stimulated with either 
medium or various doses of IL-la and the concentrations 
of IL-8 in the culture supernatants were determined at 8 h 
(a) and 24 h (b) after cultivation. The results are 
expressed as mean * SD in three experiments. *P<O.Ol 
compared with IL-8 secretion in the culture supernatants 
from bronchial epithelial cells cultured with medium only. 
EFFECT OF BHA OR PDTC ON IL-la-INDUCED 
IL-8 SECRETION 
EFFECT OF NAC ON IL-la-INDUCED IL-8 
SECRETION 
In the next experiments, the culture supernatants from 
BEAS-2B stimulated with 100 ng ml- ’ of IL-la were har- 
vested at 24 h after cultivation to examine the effect of 
NAC on IL-8 secretion. NAC showed a dose-dependent 
inhibitory effect on IL-la-induced IL-8 secretion by 
BEAS-2B (Fig 2). 
We examined the effect of other antioxidants, such as BHA 
and PDTC, on IL-la-induced IL-8 secretion by BEAS-2B. 
BEAS-2B that had been preincubated with various concen- 
trations of BHA or PDTC were stimulated with IL-la and 
cultured for 24 h. Both BHA and PDTC showed a dose- 
dependent inhibitory effect on IL-la-induced IL-8 secretion 
by BEAS-2B (Fig. 3). To test the possibility that NAC, 
BHA and PDTC could physically alter IL-la molecules, the 
following experiment was performed. Bronchial epithelial 
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FIG. 2. Dose-related inhibition by NAC of IL-8 secretion 
by IL-la-stimulated bronchial epithelial cells. Bronchial 
epithelial cells that had been pre-incubated with or with- 
out several doses of NAC were stimulated with either 
medium (0) or 100 ng ml - i of IL-la (0) and the concen- 
trations of IL-8 in the culture supernatants were deter- 
mined at 24 h after cultivation. The results are expressed 
as mean f SD in three experiments. *P<O.Ol compared 
with IL-la-induced IL-8 secretion in the absence of NAC. 
cells that had been preincubated with or without NAC were 
rinsed three times with medium at the end of preincubation 
periods, and then the cells were stimulated with IL-la. The 
percentage of inhibitory effects of NAC (10 mu) on IL-8 
secretion in this experimental procedure (48.2 f 5.6%, 
mean f SD in three experiments) was comparable to that 
indicated in Fig. 3 (51.2 f 6.2%), indicating that NAC did 
not physically alter IL-la molecules. Similar results were 
obtained in BHA or PDTC treatment (data not shown). At 
the end of culture periods, the total number of cells and cell 
viability determined by trypan blue exclusion dye assay 
did not differ with the culture conditions indicated in 
Figs 1 to 3 (data not shown). 
Discussion 
Our results showed that NAC inhibited IL-8 secretion by 
IL-la-stimulated bronchial epithelial cells. Similarly, other 
antioxidants, such as BHA and PDTC (13-l 5), exhibited an 
inhibitory effect on IL-8 secretion by bronchial epithelial 
cells. The present study showed for the first time the ability 
of NAC to inhibit IL-8 secretion by IL-la-stimulated 
bronchial epithelial cells. 
The important role of the oxidant-antioxidant balance in 
the pathogenesis of acute lung injury has been described 
(17,18). NAC has been used in the treatment of experimen- 
tal and clinical acute lung injury. It has been suggested that 
the protective effects of NAC on acute lung injury are due 
to scavenging ROIs and stimulation of glutathione syn- 
thesis (3-5,8,12). Since the neutrophil is a major source of 
ROIs (17) the inhibition of IL-8 secretion which acts on 
recruitment of neutrophils at the site of inflammation is 
thought to be an important strategy for protection against 
pathogenesis in acute lung injury. Therefore, our results 
with NAGdependent inhibition of IL-8 secretion provide 
an alternative explanation for the protective role of NAC 
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FIG. 3. Dose-related inhibition by BHA or PDTC of IL-8 
secretion by IL-la-stimulated bronchial epithelial cells. 
Bronchial epithelial cells that had been preincubated with 
or without several doses of BHA or PDTC were stimu- 
lated with either medium (0) or 100 ng ml - ’ of IL-la (0) 
and the concentrations of IL-8 in the culture supematants 
were determined at 24 h after cultivation. The results are 
expressed as mean k SD in three experiments. *P<O.Ol 
compared with IL-la-induced IL-8 secretion in the 
absence of BHA or PDTC. 
on acute lung injury. In addition, Leff et al. (10) have shown 
that NAC decreased neutrophil influx into lung lavages in 
IL-la-induced acute lung injury. Our results might support 
this evidence. 
There are several mechanisms by which NAC inhibits 
IL-8 secretion by IL-la-stimulated bronchial epithelial 
cells. The promotor of the gene encoding IL-8 contains 
sequences for binding several nuclear transcription factors, 
including NF-KB (18,19). These transcription factors par- 
ticipate to various extents in the inducible expression of the 
gene encoding IL-8. Antioxidant NAC, which scavenges 
ROIs, has been shown to inhibit the activation of NF-K-B 
(15,20). Therefore, the inhibition of IL-8 secretion by NAC 
might be mediated, at least in part, through the inhibition 
of ROl-induced NF-KB activation by which NAC scavenges 
ROIs. In support of this, the structurally unrelated anti- 
oxidants BHA and PDTC (13-l 5) also effectively inhibited 
IL-8 secretion. Although a precise mechanism for the 
inhibition of IL-8 secretion by antioxidants such as 
NAC, BHA and PDTC remains to be determined, an 
antioxidant-sensitive mechanism might be involved in the 
inhibition of IL-8 secretion by IL-la-stimulated bronchial 
epithelial cells. 
In conclusion, our study demonstrated that NAC inhib- 
ited IL-8 secretion by IL-la-stimulated bronchial epithelial 
cells. These results may provide an alternative explanation 
for the efficacy of NAC on acute lung injury. 
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